2-84653321-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001370.2(DNAH6):​c.5081G>C​(p.Gly1694Ala) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.128 in 1,505,824 control chromosomes in the GnomAD database, including 12,907 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 986 hom., cov: 32)
Exomes 𝑓: 0.13 ( 11921 hom. )

Consequence

DNAH6
NM_001370.2 missense, splice_region

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 6.17

Publications

12 publications found
Variant links:
Genes affected
DNAH6 (HGNC:2951): (dynein axonemal heavy chain 6) This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Mutations in this gene may cause primary ciliary dyskinesia (PCD) as well as heterotaxy. [provided by RefSeq, Jun 2016]
DNAH6 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020864606).
BP6
Variant 2-84653321-G-C is Benign according to our data. Variant chr2-84653321-G-C is described in ClinVar as [Benign]. Clinvar id is 402738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.132 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH6NM_001370.2 linkc.5081G>C p.Gly1694Ala missense_variant, splice_region_variant Exon 34 of 77 ENST00000389394.8 NP_001361.1 Q9C0G6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH6ENST00000389394.8 linkc.5081G>C p.Gly1694Ala missense_variant, splice_region_variant Exon 34 of 77 5 NM_001370.2 ENSP00000374045.3 Q9C0G6-1

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
16774
AN:
151970
Hom.:
987
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0718
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.119
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.0693
Gnomad SAS
AF:
0.130
Gnomad FIN
AF:
0.0802
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.134
Gnomad OTH
AF:
0.133
GnomAD2 exomes
AF:
0.118
AC:
14938
AN:
127044
AF XY:
0.120
show subpopulations
Gnomad AFR exome
AF:
0.0672
Gnomad AMR exome
AF:
0.0959
Gnomad ASJ exome
AF:
0.182
Gnomad EAS exome
AF:
0.0617
Gnomad FIN exome
AF:
0.0771
Gnomad NFE exome
AF:
0.139
Gnomad OTH exome
AF:
0.138
GnomAD4 exome
AF:
0.129
AC:
175272
AN:
1353736
Hom.:
11921
Cov.:
31
AF XY:
0.131
AC XY:
86900
AN XY:
663372
show subpopulations
African (AFR)
AF:
0.0710
AC:
2095
AN:
29526
American (AMR)
AF:
0.0953
AC:
2593
AN:
27216
Ashkenazi Jewish (ASJ)
AF:
0.180
AC:
4086
AN:
22734
East Asian (EAS)
AF:
0.0698
AC:
2458
AN:
35238
South Asian (SAS)
AF:
0.134
AC:
9775
AN:
72872
European-Finnish (FIN)
AF:
0.0765
AC:
3660
AN:
47850
Middle Eastern (MID)
AF:
0.203
AC:
1105
AN:
5446
European-Non Finnish (NFE)
AF:
0.134
AC:
142066
AN:
1056944
Other (OTH)
AF:
0.133
AC:
7434
AN:
55910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
6844
13688
20533
27377
34221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5206
10412
15618
20824
26030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.110
AC:
16775
AN:
152088
Hom.:
986
Cov.:
32
AF XY:
0.108
AC XY:
8055
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0717
AC:
2975
AN:
41508
American (AMR)
AF:
0.119
AC:
1813
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
599
AN:
3466
East Asian (EAS)
AF:
0.0688
AC:
357
AN:
5186
South Asian (SAS)
AF:
0.131
AC:
629
AN:
4816
European-Finnish (FIN)
AF:
0.0802
AC:
849
AN:
10582
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.134
AC:
9103
AN:
67960
Other (OTH)
AF:
0.133
AC:
281
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
767
1534
2301
3068
3835
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.131
Hom.:
999
Bravo
AF:
0.109
TwinsUK
AF:
0.132
AC:
489
ALSPAC
AF:
0.127
AC:
490
ESP6500AA
AF:
0.0744
AC:
103
ESP6500EA
AF:
0.134
AC:
425
ExAC
AF:
0.111
AC:
2737
Asia WGS
AF:
0.0980
AC:
340
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH6-related disorder Benign:1
Oct 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Benign
0.84
DEOGEN2
Benign
0.068
T;T
Eigen
Benign
0.024
Eigen_PC
Benign
0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D;.
MetaRNN
Benign
0.0021
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.74
N;N
PhyloP100
6.2
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-2.6
D;D
REVEL
Benign
0.079
Sift
Benign
0.45
T;T
Polyphen
0.15
B;B
Vest4
0.28
MPC
0.11
ClinPred
0.017
T
GERP RS
5.0
Varity_R
0.32
gMVP
0.63
Mutation Taster
=41/59
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28375417; hg19: chr2-84880445; COSMIC: COSV52862202; COSMIC: COSV52862202; API